nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—Dacarbazine—sarcoma	0.207	0.264	CbGbCtD
Meprobamate—CYP2E1—Mitoxantrone—sarcoma	0.161	0.205	CbGbCtD
Meprobamate—CYP2E1—Etoposide—sarcoma	0.102	0.129	CbGbCtD
Meprobamate—ABCB1—Dactinomycin—sarcoma	0.091	0.116	CbGbCtD
Meprobamate—ABCB1—Mitoxantrone—sarcoma	0.0814	0.104	CbGbCtD
Meprobamate—ABCB1—Vincristine—sarcoma	0.056	0.0714	CbGbCtD
Meprobamate—ABCB1—Etoposide—sarcoma	0.0513	0.0654	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—sarcoma	0.035	0.0446	CbGbCtD
Meprobamate—Proctitis—Dactinomycin—sarcoma	0.0142	0.0661	CcSEcCtD
Meprobamate—Thrombocytopenic purpura—Thiotepa—sarcoma	0.00747	0.0347	CcSEcCtD
Meprobamate—Proctitis—Epirubicin—sarcoma	0.00578	0.0268	CcSEcCtD
Meprobamate—Proctitis—Doxorubicin—sarcoma	0.00534	0.0248	CcSEcCtD
Meprobamate—Anuria—Epirubicin—sarcoma	0.00404	0.0187	CcSEcCtD
Meprobamate—Oliguria—Thiotepa—sarcoma	0.0038	0.0176	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—sarcoma	0.00373	0.0173	CcSEcCtD
Meprobamate—Petechiae—Mitoxantrone—sarcoma	0.00368	0.0171	CcSEcCtD
Meprobamate—Aplastic anaemia—Dactinomycin—sarcoma	0.00326	0.0152	CcSEcCtD
Meprobamate—Ecchymosis—Mitoxantrone—sarcoma	0.00273	0.0127	CcSEcCtD
Meprobamate—Ataxia—Thiotepa—sarcoma	0.00239	0.0111	CcSEcCtD
Meprobamate—Rash maculo-papular—Etoposide—sarcoma	0.00229	0.0106	CcSEcCtD
Meprobamate—Ataxia—Vincristine—sarcoma	0.00212	0.00984	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00193	0.00895	CcSEcCtD
Meprobamate—Stomatitis—Thiotepa—sarcoma	0.00191	0.00887	CcSEcCtD
Meprobamate—Stomatitis—Dactinomycin—sarcoma	0.0019	0.0088	CcSEcCtD
Meprobamate—Agranulocytosis—Thiotepa—sarcoma	0.00183	0.00849	CcSEcCtD
Meprobamate—Agranulocytosis—Dactinomycin—sarcoma	0.00181	0.00843	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—sarcoma	0.00171	0.00796	CcSEcCtD
Meprobamate—Stomatitis—Vincristine—sarcoma	0.00169	0.00786	CcSEcCtD
Meprobamate—Drowsiness—Mitoxantrone—sarcoma	0.00169	0.00786	CcSEcCtD
Meprobamate—Erythema multiforme—Dactinomycin—sarcoma	0.00165	0.00766	CcSEcCtD
Meprobamate—Stomatitis—Mitoxantrone—sarcoma	0.00165	0.00766	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—sarcoma	0.00159	0.00736	CcSEcCtD
Meprobamate—Agranulocytosis—Mitoxantrone—sarcoma	0.00158	0.00733	CcSEcCtD
Meprobamate—Chills—Thiotepa—sarcoma	0.00158	0.00733	CcSEcCtD
Meprobamate—Arrhythmia—Thiotepa—sarcoma	0.00157	0.0073	CcSEcCtD
Meprobamate—Chills—Dactinomycin—sarcoma	0.00157	0.00727	CcSEcCtD
Meprobamate—Bronchospasm—Etoposide—sarcoma	0.00155	0.00721	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—sarcoma	0.00153	0.00711	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—sarcoma	0.00149	0.00692	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—sarcoma	0.00142	0.00657	CcSEcCtD
Meprobamate—Agitation—Thiotepa—sarcoma	0.00141	0.00653	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Etoposide—sarcoma	0.0014	0.00648	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—sarcoma	0.00138	0.00641	CcSEcCtD
Meprobamate—Stomatitis—Etoposide—sarcoma	0.00137	0.00637	CcSEcCtD
Meprobamate—Leukopenia—Thiotepa—sarcoma	0.00137	0.00636	CcSEcCtD
Meprobamate—Chills—Mitoxantrone—sarcoma	0.00136	0.00633	CcSEcCtD
Meprobamate—Leukopenia—Dactinomycin—sarcoma	0.00136	0.00632	CcSEcCtD
Meprobamate—Arrhythmia—Mitoxantrone—sarcoma	0.00136	0.0063	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—sarcoma	0.00132	0.00615	CcSEcCtD
Meprobamate—Agranulocytosis—Etoposide—sarcoma	0.00131	0.0061	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—sarcoma	0.00128	0.00595	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—sarcoma	0.00127	0.00592	CcSEcCtD
Meprobamate—Agitation—Vincristine—sarcoma	0.00125	0.00579	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—sarcoma	0.00123	0.00569	CcSEcCtD
Meprobamate—Vertigo—Vincristine—sarcoma	0.00122	0.00566	CcSEcCtD
Meprobamate—Tachycardia—Thiotepa—sarcoma	0.00122	0.00566	CcSEcCtD
Meprobamate—Leukopenia—Vincristine—sarcoma	0.00122	0.00564	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—sarcoma	0.0012	0.00557	CcSEcCtD
Meprobamate—Erythema multiforme—Etoposide—sarcoma	0.00119	0.00555	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—sarcoma	0.00119	0.00551	CcSEcCtD
Meprobamate—Leukopenia—Mitoxantrone—sarcoma	0.00118	0.0055	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—sarcoma	0.00118	0.00548	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—sarcoma	0.00114	0.00531	CcSEcCtD
Meprobamate—Chills—Etoposide—sarcoma	0.00113	0.00526	CcSEcCtD
Meprobamate—Paraesthesia—Thiotepa—sarcoma	0.00112	0.00521	CcSEcCtD
Meprobamate—Somnolence—Thiotepa—sarcoma	0.00111	0.00516	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—sarcoma	0.00111	0.00515	CcSEcCtD
Meprobamate—Anaphylactic shock—Vincristine—sarcoma	0.00111	0.00514	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—sarcoma	0.00108	0.00504	CcSEcCtD
Meprobamate—Anaphylactic shock—Mitoxantrone—sarcoma	0.00108	0.00501	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—sarcoma	0.00107	0.00497	CcSEcCtD
Meprobamate—Purpura—Epirubicin—sarcoma	0.00106	0.00493	CcSEcCtD
Meprobamate—Shock—Mitoxantrone—sarcoma	0.00106	0.00493	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—sarcoma	0.00106	0.00492	CcSEcCtD
Meprobamate—Tachycardia—Mitoxantrone—sarcoma	0.00105	0.00489	CcSEcCtD
Meprobamate—Hypotension—Vincristine—sarcoma	0.00104	0.00481	CcSEcCtD
Meprobamate—Hypotension—Mitoxantrone—sarcoma	0.00101	0.00468	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—sarcoma	0.001	0.00466	CcSEcCtD
Meprobamate—Paraesthesia—Vincristine—sarcoma	0.000995	0.00462	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—sarcoma	0.000991	0.0046	CcSEcCtD
Meprobamate—Vertigo—Etoposide—sarcoma	0.000988	0.00459	CcSEcCtD
Meprobamate—Body temperature increased—Thiotepa—sarcoma	0.000988	0.00459	CcSEcCtD
Meprobamate—Leukopenia—Etoposide—sarcoma	0.000984	0.00457	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—sarcoma	0.000983	0.00456	CcSEcCtD
Meprobamate—Body temperature increased—Dactinomycin—sarcoma	0.00098	0.00455	CcSEcCtD
Meprobamate—Paraesthesia—Mitoxantrone—sarcoma	0.000969	0.0045	CcSEcCtD
Meprobamate—Loss of consciousness—Etoposide—sarcoma	0.000967	0.00449	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—sarcoma	0.000963	0.00447	CcSEcCtD
Meprobamate—Somnolence—Mitoxantrone—sarcoma	0.000959	0.00445	CcSEcCtD
Meprobamate—Hypersensitivity—Thiotepa—sarcoma	0.000921	0.00427	CcSEcCtD
Meprobamate—Hypersensitivity—Dactinomycin—sarcoma	0.000914	0.00424	CcSEcCtD
Meprobamate—Anaphylactic shock—Etoposide—sarcoma	0.000898	0.00417	CcSEcCtD
Meprobamate—Asthenia—Thiotepa—sarcoma	0.000896	0.00416	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—sarcoma	0.000891	0.00414	CcSEcCtD
Meprobamate—Asthenia—Dactinomycin—sarcoma	0.00089	0.00413	CcSEcCtD
Meprobamate—Pruritus—Thiotepa—sarcoma	0.000884	0.0041	CcSEcCtD
Meprobamate—Tachycardia—Etoposide—sarcoma	0.000876	0.00407	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—sarcoma	0.000876	0.00407	CcSEcCtD
Meprobamate—Body temperature increased—Vincristine—sarcoma	0.000876	0.00407	CcSEcCtD
Meprobamate—Diarrhoea—Thiotepa—sarcoma	0.000855	0.00397	CcSEcCtD
Meprobamate—Body temperature increased—Mitoxantrone—sarcoma	0.000853	0.00396	CcSEcCtD
Meprobamate—Diarrhoea—Dactinomycin—sarcoma	0.000848	0.00394	CcSEcCtD
Meprobamate—Hypotension—Etoposide—sarcoma	0.000839	0.00389	CcSEcCtD
Meprobamate—Dizziness—Thiotepa—sarcoma	0.000826	0.00384	CcSEcCtD
Meprobamate—Hypersensitivity—Vincristine—sarcoma	0.000816	0.00379	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—sarcoma	0.000811	0.00376	CcSEcCtD
Meprobamate—Paraesthesia—Etoposide—sarcoma	0.000806	0.00374	CcSEcCtD
Meprobamate—Somnolence—Etoposide—sarcoma	0.000798	0.00371	CcSEcCtD
Meprobamate—Hypersensitivity—Mitoxantrone—sarcoma	0.000795	0.00369	CcSEcCtD
Meprobamate—Asthenia—Vincristine—sarcoma	0.000795	0.00369	CcSEcCtD
Meprobamate—Vomiting—Thiotepa—sarcoma	0.000794	0.00369	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—sarcoma	0.000789	0.00366	CcSEcCtD
Meprobamate—Vomiting—Dactinomycin—sarcoma	0.000788	0.00366	CcSEcCtD
Meprobamate—Dermatitis—Thiotepa—sarcoma	0.000787	0.00365	CcSEcCtD
Meprobamate—Headache—Thiotepa—sarcoma	0.000783	0.00363	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000782	0.00363	CcSEcCtD
Meprobamate—Asthenia—Mitoxantrone—sarcoma	0.000774	0.00359	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—sarcoma	0.000769	0.00357	CcSEcCtD
Meprobamate—Diarrhoea—Vincristine—sarcoma	0.000758	0.00352	CcSEcCtD
Meprobamate—Nausea—Thiotepa—sarcoma	0.000742	0.00345	CcSEcCtD
Meprobamate—Diarrhoea—Mitoxantrone—sarcoma	0.000738	0.00343	CcSEcCtD
Meprobamate—Nausea—Dactinomycin—sarcoma	0.000737	0.00342	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—sarcoma	0.000736	0.00342	CcSEcCtD
Meprobamate—Dizziness—Vincristine—sarcoma	0.000733	0.0034	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—sarcoma	0.00073	0.00339	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000724	0.00336	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—sarcoma	0.000711	0.0033	CcSEcCtD
Meprobamate—Body temperature increased—Etoposide—sarcoma	0.00071	0.00329	CcSEcCtD
Meprobamate—Vomiting—Vincristine—sarcoma	0.000704	0.00327	CcSEcCtD
Meprobamate—Dermatitis—Vincristine—sarcoma	0.000698	0.00324	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—sarcoma	0.000698	0.00324	CcSEcCtD
Meprobamate—Headache—Vincristine—sarcoma	0.000694	0.00322	CcSEcCtD
Meprobamate—Vomiting—Mitoxantrone—sarcoma	0.000686	0.00319	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—sarcoma	0.000681	0.00316	CcSEcCtD
Meprobamate—Dermatitis—Mitoxantrone—sarcoma	0.00068	0.00316	CcSEcCtD
Meprobamate—Headache—Mitoxantrone—sarcoma	0.000676	0.00314	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—sarcoma	0.00067	0.00311	CcSEcCtD
Meprobamate—Hypersensitivity—Etoposide—sarcoma	0.000661	0.00307	CcSEcCtD
Meprobamate—Nausea—Vincristine—sarcoma	0.000658	0.00306	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—sarcoma	0.000645	0.003	CcSEcCtD
Meprobamate—Asthenia—Etoposide—sarcoma	0.000644	0.00299	CcSEcCtD
Meprobamate—Nausea—Mitoxantrone—sarcoma	0.000641	0.00298	CcSEcCtD
Meprobamate—Chills—Epirubicin—sarcoma	0.000635	0.00295	CcSEcCtD
Meprobamate—Pruritus—Etoposide—sarcoma	0.000635	0.00295	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—sarcoma	0.000633	0.00294	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—sarcoma	0.00062	0.00288	CcSEcCtD
Meprobamate—Diarrhoea—Etoposide—sarcoma	0.000614	0.00285	CcSEcCtD
Meprobamate—Dizziness—Etoposide—sarcoma	0.000594	0.00276	CcSEcCtD
Meprobamate—Chills—Doxorubicin—sarcoma	0.000588	0.00273	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—sarcoma	0.000585	0.00272	CcSEcCtD
Meprobamate—Vomiting—Etoposide—sarcoma	0.000571	0.00265	CcSEcCtD
Meprobamate—Agitation—Epirubicin—sarcoma	0.000566	0.00263	CcSEcCtD
Meprobamate—Dermatitis—Etoposide—sarcoma	0.000565	0.00263	CcSEcCtD
Meprobamate—Headache—Etoposide—sarcoma	0.000562	0.00261	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—sarcoma	0.000554	0.00257	CcSEcCtD
Meprobamate—Syncope—Epirubicin—sarcoma	0.000553	0.00257	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—sarcoma	0.000552	0.00256	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—sarcoma	0.000545	0.00253	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—sarcoma	0.000542	0.00252	CcSEcCtD
Meprobamate—Nausea—Etoposide—sarcoma	0.000533	0.00248	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—sarcoma	0.000524	0.00243	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—sarcoma	0.000512	0.00238	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—sarcoma	0.000512	0.00238	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—sarcoma	0.000511	0.00237	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—sarcoma	0.000504	0.00234	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—sarcoma	0.000503	0.00234	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—sarcoma	0.000501	0.00233	CcSEcCtD
Meprobamate—Shock—Epirubicin—sarcoma	0.000495	0.0023	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—sarcoma	0.000491	0.00228	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—sarcoma	0.00047	0.00218	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—sarcoma	0.000466	0.00216	CcSEcCtD
Meprobamate—Shock—Doxorubicin—sarcoma	0.000458	0.00213	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—sarcoma	0.000454	0.00211	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—sarcoma	0.000452	0.0021	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—sarcoma	0.000447	0.00208	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—sarcoma	0.000435	0.00202	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—sarcoma	0.000418	0.00194	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—sarcoma	0.000414	0.00192	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—sarcoma	0.000398	0.00185	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—sarcoma	0.000371	0.00172	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—sarcoma	0.000368	0.00171	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—sarcoma	0.000361	0.00168	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—sarcoma	0.000356	0.00165	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—sarcoma	0.000344	0.0016	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—sarcoma	0.000343	0.00159	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—sarcoma	0.000334	0.00155	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—sarcoma	0.000333	0.00154	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—sarcoma	0.000329	0.00153	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—sarcoma	0.00032	0.00149	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—sarcoma	0.000319	0.00148	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—sarcoma	0.000317	0.00147	CcSEcCtD
Meprobamate—Headache—Epirubicin—sarcoma	0.000315	0.00146	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—sarcoma	0.000308	0.00143	CcSEcCtD
Meprobamate—Nausea—Epirubicin—sarcoma	0.000299	0.00139	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—sarcoma	0.000296	0.00137	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—sarcoma	0.000293	0.00136	CcSEcCtD
Meprobamate—Headache—Doxorubicin—sarcoma	0.000292	0.00135	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—sarcoma	0.000277	0.00128	CcSEcCtD
